![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 22, 2013 2:19:17 PM
Bunny's recent post inspired me to do a little web crawling.
From DaBoze:
I cannot recall a single instance where the NNVC management has not produced the results they predicted. In the long run that's all that will matter.
Among the "results they [NNVC management] predicted" are the timelines for the testing and approval of various nanoviricides. All images here were taken from past versions of Nanoviricide's web site, courtesy of the Wayback Machine:
July 14, 2005 - we were supposed to have a cure for AIDS by the end of 2009:
![](http://i1276.photobucket.com/albums/y461/jeg36/NNVC/July-14-2005_zps7ff894bb.png)
December 20, 2005 - The cure for AIDS has been delayed a year. Flucide appears -- Glory be! It completed phase 3 trials in 2010 and has no doubt been in the pharmacies for over 2 years. Who knew?
![](http://i1276.photobucket.com/albums/y461/jeg36/NNVC/Dec-20-2005_zps1905f2df.png)
December 13, 2007 - Oops, looks like Flucide completed phase 3 trials in 2011, not 2010. But at least we go a cure for rabies in the same year. That AIDS schedule has slipped too.
![](http://i1276.photobucket.com/albums/y461/jeg36/NNVC/Dec-13-2007_zps0bcdaa2f.png)
February 20, 2009 -- Nanovirides' management finally gets smart. Their pipelines no longer have any dates.
![](http://i1276.photobucket.com/albums/y461/jeg36/NNVC/Feb-20-2009_zpse827703e.png)
Yes, Seaside keeps tossing more shares over the fence. But if NNVC was the near sure 200 bagger that the boosters here think, the smart money would be on the other side of that fence snapping up every share and the price wouldn't be in the low .40s. I think the above images explain why the smart money is AWOL.
Also, if you look at the second image you can see that the time to get the IND approval, do tox studies, phase I, phase II, and phase III trials spans from early 2006 to early 2010, so that wildly optimistic chart estimated 4 years for those items. Today we need an IND approval, tox studies, phase I, phase II, and phase III trials, and the construction of a manufacturing facility, and yet the boosters here say that can all be done in 2 years!
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM